DapaCombi Tablet 10/100 Milligrams
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
MFDS item code 202108046 · Approved 2021.12.21
Improvement in blood sugar control in type 2 diabetes
This medication is used in combination with sitagliptin and dapagliflozin to help control blood sugar levels in patients with type 2 diabetes and supports dietary and exercise management. It effectively lowers blood sugar levels, aiding in diabetes management and improving therapeutic outcomes for patients.
This medication may be administered to patients taking 100 mg of sitagliptin and 10 mg of dapagliflozin at a dose of 1 tablet once daily, irrespective of meals. The tablet should be swallowed whole.
This medication contains sitagliptin and dapagliflozin and is used for diabetes treatment. First, serious allergic reactions may occur while taking this medication, so if symptoms of hypersensitivity such as skin rash or difficulty breathing appear, immediately stop taking the medication and consult a physician. Additionally, this medication may cause a serious pancreatic inflammation known as pancreatitis. If severe abdominal pain or vomiting occurs, promptly inform medical personnel. This medication should not be administered to certain patients, such as those who are allergic to the ingredients or patients with type 1 diabetes, those undergoing renal dialysis, and patients with lactose intolerance. Use with caution in patients with low fluid volume or poor kidney function, as hypotension or worsening renal function may occur; regular kidney function tests and blood pressure monitoring are necessary. This medication may increase the risk of genital and urinary tract infections. If symptoms of infection (itching, pain, discharge, etc.) arise, immediate treatment is required. Due to its blood sugar-lowering effect, there is a risk of hypoglycemia when taken with insulin or other blood sugar-lowering agents, so patients should be aware of hypoglycemic symptoms and may need dose adjustments as necessary. It is recommended that pregnant or breastfeeding women avoid this medication, and if pregnancy is confirmed, discontinue use immediately. Elderly patients or those with impaired kidney function should adjust the dose of this medication and regularly monitor kidney function. In the case of overdose, there is no specific antidote, so it is crucial to receive appropriate treatment based on symptoms. Finally, caution should be taken while driving or operating machinery during treatment, as there is a risk of hypoglycemia.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, serious skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, coughing accompanied by fever and respiratory abnormalities, respiratory problems, yellowing of skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice), sudden onset.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer period.
Yellow rectangular film-coated tablet
28 tablets/box - 28 tablets/box[(7 tablets/PTP x 4)], 30 tablets/box - 30 tablets/box[(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Ilsung IS Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
Sitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Dapagliflozin citric acid 14.7mg
Tablet · Prescription medication · Combination
Chodang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.